Landscapes / Companies
Advenchen Pharmaceuticals, LLC. not checked
FollowEvery new trial, moved date and filing, and a Monday email
Drugs
3
in active trials
Trials
3 active
3 since 2021
Drugs3
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
— |
Advenchen Laboratories |
Approved in China | 1 Sep 2030Phase 1/2 trial completes | ||
| Next date | 1 Sep 2030 · Phase 1/2 trial completes | ||||
| Also tested for | Endometrial Neoplasms, Ovarian Neoplasms and 2 more | ||||
| Open drug page | |||||
— |
Advenchen Laboratories Nanjing |
Phase 2 | Dec 2027Phase 2 trial completes | ||
| Next date | Dec 2027 · Phase 2 trial completes | ||||
| Also tested for | Small Cell Lung Cancer, Renal Cell Carcinoma (RCC) and 4 more | ||||
| Open drug page | |||||
— |
Phase 1/2 | 1 Sep 2030Phase 1/2 trial completes | |||
| Next date | 1 Sep 2030 · Phase 1/2 trial completes | ||||
| Also tested for | Endometrial Neoplasms, Soft Tissue Sarcoma (STS) and 4 more | ||||
| Open drug page | |||||
About
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 Industry-sponsored drug trials since 2021